Zobrazeno 1 - 10
of 326
pro vyhledávání: '"M, Brownstein"'
Autor:
Rachel M. Brownstein
Publikováno v:
Jane Austen, Sex, and Romance. :154-159
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50466dbe2e2a36c254fdc867108b41d0
https://doi.org/10.1017/9781800106758.010
https://doi.org/10.1017/9781800106758.010
Autor:
David G. Kirsch, Marco Durante, Sin-Ho Jung, Nerissa Williams, Yan Ma, Lorraine Da Silva Campos, Lixia Luo, Junheng Gao, Emanuele Scifoni, Chiara La Tessa, Francesco Tommasino, Chang-Lung Lee, Peter Guida, Yvonne M. Mowery, Katherine D. Castle, Amy J. Wisdom, Jeremy M. Brownstein
Carbon ion therapy (CIT) offers several potential advantages for treating cancers compared with X-ray and proton radiotherapy, including increased biological efficacy and more conformal dosimetry. However, CIT potency has not been characterized in pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93b9420ceb5ee9a00c3da8ae2806acd3
https://doi.org/10.1158/1535-7163.c.6538128.v1
https://doi.org/10.1158/1535-7163.c.6538128.v1
Autor:
David G. Kirsch, Marco Durante, Sin-Ho Jung, Nerissa Williams, Yan Ma, Lorraine Da Silva Campos, Lixia Luo, Junheng Gao, Emanuele Scifoni, Chiara La Tessa, Francesco Tommasino, Chang-Lung Lee, Peter Guida, Yvonne M. Mowery, Katherine D. Castle, Amy J. Wisdom, Jeremy M. Brownstein
Serial tumor volume measurements on individual mice. Absolute tumor volume in mm3 is shown for individual mice on each measurement day following irradiation (in treated mice) or once tumors reached 40 mm3 (in untreated controls). Measurements were ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b2a0020b29574b7df03cf7da21dede1
https://doi.org/10.1158/1535-7163.22505592.v1
https://doi.org/10.1158/1535-7163.22505592.v1
Autor:
David G. Kirsch, Marco Durante, Sin-Ho Jung, Nerissa Williams, Yan Ma, Lorraine Da Silva Campos, Lixia Luo, Junheng Gao, Emanuele Scifoni, Chiara La Tessa, Francesco Tommasino, Chang-Lung Lee, Peter Guida, Yvonne M. Mowery, Katherine D. Castle, Amy J. Wisdom, Jeremy M. Brownstein
Comparing the effect anesthetic agent and housing location on tumor quintupling. A) Tumor quintupling times in mice treated with 20 Gy X-rays who were anesthetized with ketamine/xylazine vs. isoflurane, demonstrating no significant differences. B) Tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::692378197f82e0b6437a49bef075d5b1
https://doi.org/10.1158/1535-7163.22505601
https://doi.org/10.1158/1535-7163.22505601
Autor:
David G. Kirsch, Marco Durante, Sin-Ho Jung, Nerissa Williams, Yan Ma, Lorraine Da Silva Campos, Lixia Luo, Junheng Gao, Emanuele Scifoni, Chiara La Tessa, Francesco Tommasino, Chang-Lung Lee, Peter Guida, Yvonne M. Mowery, Katherine D. Castle, Amy J. Wisdom, Jeremy M. Brownstein
Quantification of TUNEL staining for sarcomas at 24 or 48 hours after 10 Gy carbon ions or 30 Gy X-rays. A) TUNEL staining was similar, indicating that there were no significant differences in cell death. B) TUNEL staining at 24 and 48 hours.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::399dccf2bdf435546f5da4c11a2c2a74
https://doi.org/10.1158/1535-7163.22505595.v1
https://doi.org/10.1158/1535-7163.22505595.v1
Autor:
Lillian L. Siu, A. Thomas DiCioccio, Bo Gao, Pamela A. Trail, Ana Kostic, Israel Lowy, Carrie M. Brownstein, Lieve Adriaens, Muralidhar Beeram, Ariceli A. Alfaro, Philippe L. Bedard, Amita Patnaik, Katherine Van Loon, Albiruni R. Abdul Razak, Anthony W. Tolcher, Robin Kate Kelley, Kyriakos P. Papadopoulos
Supplementary Figure 1 Total Nesvacumab (REGN910) and Total Ang2 vs Time (cycle 1) following IV infusion in Patients. Supplementary Figure 2 Serum levels of ESM1, SDF-1, PLGF-1 and sVCAM-1 following Nesvacumab (REGN910) treatment. Supplementary Figur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b578745ec3228101009b6254930a234
https://doi.org/10.1158/1078-0432.22459569.v1
https://doi.org/10.1158/1078-0432.22459569.v1
Autor:
Lillian L. Siu, A. Thomas DiCioccio, Bo Gao, Pamela A. Trail, Ana Kostic, Israel Lowy, Carrie M. Brownstein, Lieve Adriaens, Muralidhar Beeram, Ariceli A. Alfaro, Philippe L. Bedard, Amita Patnaik, Katherine Van Loon, Albiruni R. Abdul Razak, Anthony W. Tolcher, Robin Kate Kelley, Kyriakos P. Papadopoulos
Supplementary Table 1. Summary of the Most Common (>10%) Treatment-Emergent Adverse Events
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d95d0d66eb2e878f64baa73558c32397
https://doi.org/10.1158/1078-0432.22459566
https://doi.org/10.1158/1078-0432.22459566
Autor:
Lillian L. Siu, A. Thomas DiCioccio, Bo Gao, Pamela A. Trail, Ana Kostic, Israel Lowy, Carrie M. Brownstein, Lieve Adriaens, Muralidhar Beeram, Ariceli A. Alfaro, Philippe L. Bedard, Amita Patnaik, Katherine Van Loon, Albiruni R. Abdul Razak, Anthony W. Tolcher, Robin Kate Kelley, Kyriakos P. Papadopoulos
Purpose: Nesvacumab (REGN910) is a fully human immunoglobulin G1 (IgG1) monoclonal antibody that specifically binds and inactivates the Tie2 receptor ligand Ang2 with high affinity, but shows no binding to Ang1. The main objectives of this trial were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72ba75e7ff8642325f8e0a03ff01c2a6
https://doi.org/10.1158/1078-0432.c.6524247
https://doi.org/10.1158/1078-0432.c.6524247
Autor:
Lillian L. Siu, A. Thomas DiCioccio, Bo Gao, Pamela A. Trail, Ana Kostic, Israel Lowy, Carrie M. Brownstein, Lieve Adriaens, Muralidhar Beeram, Ariceli A. Alfaro, Philippe L. Bedard, Amita Patnaik, Katherine Van Loon, Albiruni R. Abdul Razak, Anthony W. Tolcher, Robin Kate Kelley, Kyriakos P. Papadopoulos
Supplementary Data. Study entry criteria specific to patients with HCC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b1e22e2c7b7e956637fa945e369566f
https://doi.org/10.1158/1078-0432.22459572.v1
https://doi.org/10.1158/1078-0432.22459572.v1